Last reviewed · How we verify
Aplastic anemia
Approved treatments
- Nplate · Amgen
Nplate works by binding to the thrombopoietin receptor to stimulate platelet production. - Anadrol-50 · Pharmobedient
- Nplate · Nantes University Hospital
Pipeline
- Anti-human thymocyte immunoglobulin, equine · Pfizer Inc. — preclinical
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Aplastic anemia patent landscape — cliff calendar, originator estates, attackable patents
- Aplastic anemia treatment landscape brief
- Aplastic anemia treatment updates RSS
Frequently asked questions about Aplastic anemia
What drugs treat Aplastic anemia?
Tracked treatments include Nplate, Anadrol-50.
What is the treatment for Aplastic anemia?
Standard treatment for Aplastic anemia includes Nplate, Anadrol-50. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Aplastic anemia?
1 pipeline drugs tracked. Top candidates: Anti-human thymocyte immunoglobulin, equine.
Related
- Treatment landscape: Aplastic anemia patent cliff · Aplastic anemia CI report
- Treatment: Nplate · Amgen
- Treatment: Anadrol-50 · Pharmobedient
- Treatment: Nplate · Nantes University Hospital
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing